On November 15, the Biofund's portfolio company of the RVC National BioService opened the NBS-YUG biobank on the basis of the Research Institute of Medical Primatology of the Ministry of Science and Higher Education of Russia.
Biofund RVC's portfolio company National Bioservice opened a laboratory on November 23 in the Skolkovo Technopark. It has been the third laboratory by this company; the other two are located in St. Petersburg and Nizhny Novgorod.
The BioFund of RVC (Biopharmaceutical Investments of RVC LLC) increased its stake, from 54.44% to 69.48%, in PrimeBioMed, a research and production company which accumulates achievements in the field of molecular and cellular diagnostics.
An annual ranking of the activity of Russian venture capital funds from Firrma was published, which acts as a strategic partner of RVC partner — EY. According to the rating results, in 2016 the funds made 390 deals - a quarter more than in the previous year.